Hudson Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Hudson Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.3M	Buy	109,354 +233	+0.2%	+$13.4K	1.52%	27
2026 Q1	$6.62M	Buy	109,121 +6,169	+6%	+$360K	1.71%	20
2025 Q4	$5.55M	Buy	102,952 +6,328	+7%	+$304K	1.39%	34
2025 Q3	$4.36M	Buy	96,624 +7,760	+9%	+$362K	1.16%	40
2025 Q2	$4.11M	Buy	88,864 +2,551	+3%	+$125K	1.17%	41
2025 Q1	$5.26M	Buy	86,313 +4,182	+5%	+$244K	1.6%	20
2024 Q4	$4.65M	Sell	82,131 -6,518	-7%	-$364K	1.44%	31
2024 Q3	$4.59M	Buy	88,649 +1,042	+1%	+$48.9K	1.46%	34
2024 Q2	$3.64M	Buy	87,607 +19,113	+28%	+$855K	1.22%	41
2024 Q1	$3.71M	Buy	68,494 +6,641	+11%	+$338K	1.28%	38
2023 Q4	$3.17M	Buy	61,853 +7,558	+14%	+$397K	1.15%	44
2023 Q3	$3.15M	Buy	54,295 +8,798	+19%	+$539K	1.26%	41
2023 Q2	$2.91M	Buy	45,497 +3,992	+10%	+$268K	1.12%	45
2023 Q1	$2.88M	Buy	41,505 +4,096	+11%	+$289K	1.14%	41
2022 Q4	$2.69M	Buy	37,409 +2,261	+6%	+$170K	1.07%	41
2022 Q3	$2.5M	Buy	+35,148	New	+$2.55M	1.24%	23

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Hudson Capital Management's BMY Position: Q2 2026 in Review

Hudson Capital Management increased its Bristol-Myers Squibb (BMY) stake by 0.21% in Q2 2026, buying an estimated $13.4K and bringing the position to 109,354 shares worth $6.3M. The position accounts for 1.52% of the portfolio, ranked #27.

Hudson Capital Management first reported a position in BMY in Q3 2022 and has held it in 16 quarters since. The position peaked at $6.62M in Q1 2026. 818 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Hudson Capital Management held 109,354 shares of Bristol-Myers Squibb worth $6.3M as of Q2 2026.
Hudson Capital Management bought 233 Bristol-Myers Squibb shares in Q2 2026, an estimated $13.4K.
Bristol-Myers Squibb made up 1.52% of Hudson Capital Management's portfolio in Q2 2026, its #27 holding.
Hudson Capital Management first reported a position in Bristol-Myers Squibb in Q3 2022 and has held it in 16 quarters since.
Hudson Capital Management's Bristol-Myers Squibb position peaked at $6.62M in Q1 2026.
818 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hudson Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.